AstraZeneca COVID drug neutralizes omicron sub-variants in study
AstraZeneca said its antibody-based cocktail to prevent and treat COVID-19 was shown to retain neutralising activity against omicron coronavirus variants, including the highly contagiouos BA.2 sub-variant, in an independent lab study.
Data…
Read More...
Read More...